StockNews.com lowered shares of West Pharmaceutical Services (NYSE:WST – Free Report) from a buy rating to a hold rating in a research report sent to investors on Wednesday. WST has been the topic of a number of other research reports. KeyCorp boosted their price objective on West Pharmaceutical Services from $415.00 to $440.00 and gave […]
BlackRock Inc. decreased its position in West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 0.8% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 7,966,736 shares of the medical instruments supplier’s stock after selling 61,972 shares during the period. BlackRock Inc. owned approximately 0.11% of West Pharmaceutical Services worth $3,047,038,000 at the end […]
Shares of West Pharmaceutical Services, Inc. (NYSE:WST – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the five ratings firms that are currently covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The […]
BRYN MAWR TRUST Co decreased its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 24.3% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 606 shares of the medical instruments supplier’s stock after selling 194 shares during […]
Ameritas Investment Partners Inc. trimmed its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 9.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 8,286 shares of the medical instruments supplier’s stock after selling 847 shares […]